Clinical Trial Update: A Safety, Pharmacokinetics and Pharmacodynamics Study of RO6811135 in Patients With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 safety, pharmacokinetics and pharmacodynamics study of RO6811135 in patients with Type 2 diabetes mellitus con…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• RO6811135

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 1 | Status: COMPLETED